2026 Annual Public Meeting of the Board of Directors
July 21, 2026
2:30-3:30pm (eastern)
Each year, the Reagan-Udall Foundation for the FDA’s Board of Directors conducts an annual public meeting to highlight our activities in support of the U.S. Food and Drug Administration. The meeting provides an opportunity for engagement among the Foundation’s Board of Directors, FDA, and external stakeholders, including patients and consumers, regulated industry, health care providers, academics, and others dedicated to improving America’s health.
Our 2026 meeting will feature insights and Agency priorities from Acting FDA Commissioner Kyle Diamantas, JD.
The meeting will also include updates on the Foundation’s impact with Board Chair Adrian F. Hernandez, MD, MHS; Board Directors Esther Krofah, MPP, and Phuong Khanh (PK) Morrow, MD; and CEO Susan C. Winckler, RPh, Esq.
This is a hybrid event with options to attend virtually or in person at the Foundation's rooftop conference center at 1333 New Hampshire Ave. NW, Washington, DC. In-person seating is limited.
